filmov
tv
Maintenance Therapy for mCRC
Показать описание
The panel speaks to personal approaches to maintenance therapy for metastatic colorectal cancer as well as when and how to give second-line therapy.
OncLive
cancer
oncology
Рекомендации по теме
0:07:55
Maintenance Therapy for mCRC
0:04:39
Maintenance Therapy for mCRC
0:03:06
Maintenance Therapy in mCRC
0:04:57
Case 2: Maintenance Therapy in mCRC
0:05:42
mCRC: Considerations for Localized Therapy and Maintenance
0:06:01
Considering Maintenance Therapy in Metastatic Colorectal Cancer
0:04:03
Maintenance Treatment in Colorectal Cancer
0:02:07
Additional Considerations for Targeted Therapy in mCRC
0:07:59
Maintenance Therapy in Metastatic Colorectal Cancer
0:07:35
Treatment Options for Third-Line Therapy in mCRC
0:08:22
Maintenance treatment or stop and go: What is the standard? – Maintenance
0:04:44
Treatment Beyond Progression for mCRC
0:03:08
Treatment for RAS-mutated mCRC
0:09:02
Decisions in Colorectal Cancer Maintenance Therapy and Sequencing
0:05:03
Maintenance and Second-Line Decisions in mCRC
0:00:48
PanaMa: maintenance FU/FA with or without panitumumab in mCRC
0:07:14
Maintenance Therapy in Colorectal Cancer
0:02:56
FOCUS4-N: Maintenance capecitabine monotherapy in mCRC
0:03:49
mCRC: Combination Therapy and Testing
0:02:35
PANAMA: addition of maintenance panitumumab does not affect QoL in mCRC
0:01:14
Maintenance Therapy for Chemotherapy
0:05:50
PANAMA trial: Maintenance therapy with 5FU/LV plus panitumumab or 5FU/LV alone in RAS wildtype mCRC
0:01:49
FIRE-6: avelumab + FOLFIRI plus cetuximab followed by avelumab maintenance in untreated RASwt mCRC
0:07:31
Deciding Second-Line Treatment for mCRC
0:07:55
0:04:39
0:03:06
0:04:57
0:05:42
0:06:01
0:04:03
0:02:07
0:07:59
0:07:35
0:08:22
0:04:44
0:03:08
0:09:02
0:05:03
0:00:48
0:07:14
0:02:56
0:03:49
0:02:35
0:01:14
0:05:50
0:01:49
0:07:31